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independent of p53 and the hypoxic HIF signalling pathway
Abstract
Solid tumors often have an inadequate blood supply, which results in large regions that are subjected to
hypoxic or anoxic stress. Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that regulates
much of the transcriptional response of cells to hypoxia. Activating transcription factor 3 (ATF3) is
another transcription factor that responds to a variety of stresses and is often upregulated in cancer. We
investigated the regulation of ATF3 by oxygen deprivation. ATF3 induction occurred most robustly
under anoxia, is common, and it is not dependent on presence of HIF-1 or p53, but is sensitive to the
inhibition of c-Jun NH2-terminal kinase activation and the antioxidant N-acetylcystein. ATF3 could also
be induced by desferrioxamine but not by the mitochondrial poison cyanide or the nonspecific
2-oxoglutarate dioxygenase inhibitor dimethyloxalylglycine. We also show that anoxic ATF3 mRNA is
more stable than normoxic mRNA providing a mechanism for this induction. Thus, this study
demonstrates that the regulation of ATF3 under anoxia is independent of 2-oxoglutarate dioxygenase,
HIF-1 and p53, presumably involving multiple regulatory pathways.
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Abstract 
Solid tumors often have an inadequate blood supply, which results in large regions that are 
subjected to hypoxic or anoxic stress. Hypoxia inducible factor-1 is a transcription factor that 
regulates much of the transcriptional response of cells to hypoxia. Activating transcription 
factor-3 is another transcription factor that responds to a variety of stresses, and is often 
upregulated in cancer. We investigated the regulation of ATF3 by oxygen deprivation. ATF3 
induction occurred most robustly under anoxia, is common, and it is not dependent on 
presence of HIF-1 or p53, but is sensitive to the inhibition of JNK activation and the 
antioxidant N-acetylcystein. ATF3 could also be induced by desferrioxamine but not by the 
mitochondrial poison cyanide or the non-specific 2-oxoglutarate dioxygenase inhibitor 
dimethyloxalylglycine. We also show that anoxic ATF3 mRNA is more stable than normoxic 
mRNA providing a mechanism for this induction. Thus, this study demonstrates the 
regulation of ATF3 under anoxia is independent of 2-oxoglutarate dioxygenase, HIF-1 and 
p53, presumably involving multiple regulatory pathways.  
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Introduction 
Tumor hypoxia/anoxia is associated with a more aggressive clinical phenotype 
(Graeber et al., 1996; Le et al., 2004). It is thought that this phenotype is the result of the 
hypoxic induction of a number of genes, the majority of which are regulated by hypoxia 
inducible factor-1 (HIF-1) (Jiang et al., 1996). In normoxia, 2-oxoglutarate-dependent 
dioxygenases (PHDs) hydroxylate HIF-1α, which leads to interaction with the von Hippel-
Lindau protein (pVHL), targeting HIF-1α to proteasomal degradation. In hypoxia, 
hydroxylation does not occur, HIF-1α is stabilized, it binds to HIF-1β and then transactivates 
target genes (Schofield & Ratcliffe, 2004).  
Anoxia has been shown to regulate gene expression in a HIF-1 independent manner 
(Ameri et al., 2004; Blais et al., 2004). To investigate the extent and mechanisms of HIF-
independent gene regulation under low oxygen tensions, we considered activating 
transcription factor 3 (ATF3), a member of the ATF/CREB family of transcription factors, as 
a potential master regulator to alter the cellular transcriptional programs under hypoxia and 
anoxia for the following reasons. First, ATF3 is induced by a variety of stress signals (Hai et 
al., 1999). Secondly, expression of ATF3 has been demonstrated to alter a variety of cellular 
processes relevant to cancer progression including cell cycle, cell death, angiogenesis and 
metastasis (Hai & Hartman, 2001; Okamoto et al., 2006). Thirdly, ATF3 expression can be 
regulated transcriptionally by a variety of signalling pathways or transcription factors, 
including NFkB (Hartman et al., 2004), EGR-1 (Bottone et al., 2005), by p53 dependent and 
independent pathways (Amundson et al., 1999; Fan et al., 2002), and by the c-Jun NH2-
terminal kinase (JNK) (Cai et al., 2000), which is activated by MKK7 (Tournier et al., 1997). 
In addition to promoter activation, ATF3 mRNA can also accumulate as a result of mRNA 
stabilization (Liang et al., 1996). All of these pathways or regulators have been observed in 
the response of cells to hypoxia (Alfranca et al., 2002; Bottone et al., 2005; Goldberg-Cohen 
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et al., 2002; Kaelin, 2005; Scott et al., 1998).Therefore, we investigated the regulation of 
ATF3 under conditions of oxygen deprivation.  
 
Induction of ATF3 protein is a common cellular response to anoxia 
Figure 1A shows that ATF3 is robustly induced under anoxia (<0.1% O2) but not 
under hypoxic conditions (5-0.5% O2). These data suggest that HIF-1α alone is not sufficient 
to induce ATF3 as HIF-1α is stabilized in mild hypoxia. Figure 1B shows that the hypoxia-
mimetic iron chelator desferrioxamine (DFO) can also induce ATF3 and HIF-1α in MCF7 
cells. Figure 1C demonstrates that ATF3 protein is upregulated under anoxia and by DFO in a 
wide variety of different cells. One biologic difference between hypoxia and anoxia is that 
cells can continue to cycle in hypoxia while they arrest in anoxia (Papandreou et al., 2005). 
Figure 1D shows that DFO can also cause an S-phase cell cycle arrest similar to anoxia. ATF3 
can repress cyclin D1 gene expression and promote cell cycle arrest (Lu et al., 2006).  
 
ATF3 induction does not require p53, VHL, HIF2α or HIF-1α 
To determine the relative contribution of HIF-1α to induction of ATF3 under anoxia, 
we first compared a time course induction of ATF3 and HIF-1α in anoxic MCF-7 cells. The 
time course study demonstrates that ATF3 protein is not induced co-ordinately with HIF-1α 
(Figure 2A). Whereas HIF-1α is induced within 4 hours of anoxic incubation, ATF3 is 
induced after 8 hours. This suggests that a greater level or duration of oxygen depletion is 
required to upregulate ATF3 protein as compared to HIF-1α (Figure 2A). To investigate a 
direct role of HIF-1α in regulation of ATF3 under anoxia, we examined ATF3 induction in 
three model systems deficient in HIF-1α: (i) mouse embryonic fibroblasts (MEFs), (ii) RKO 
cells in which HIF-1α was inhibited by shRNA, and (iii) HIF-1β deficient Hepa-1 C4 cells. 
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Figure 2B-2D show that ATF3 was induced in all three systems, demonstrating HIF-1α is not 
necessary for the induction of ATF3 under anoxia. 
To further investigate the relationship between the HIF pathway and ATF3, we used 
786-0 cells. The 786-0 cell line is deficient in von Hippel Lindau (VHL) tumor suppressor 
and express HIF-2α at a high constitutive level but do not express HIF-1α at detectable 
levels. Stable VHL transfectants of 786-0 cells (786-0+VHL) induce HIF-2α in 
hypoxic/anoxic conditions (Maxwell et al., 1999). Both 786-0 and 786-0+VHL have low level 
ATF3 in normoxia, but induced it in anoxia. Thus, a defect in VHL and constitutive normoxic 
expression of HIF-2α is also not sufficient to induce ATF3 protein (Figure 2E).  
ATF3 has been considered as a p53 target based on CHIP-PET analysis (Wei et al., 
2006). We used the HCT116 paired p53 wild type and null cell lines to investigate whether 
p53 contributes to ATF3 induction under anoxic conditions. Our results, Figure 2F, show that 
ATF3 was equally well induced under anoxia in both wt and p53 null HCT116 cells, 
indicating that ATF3 induction does not require p53. These results are consistent with other 
reports showing that p53 does not transactivate known targets in anoxia (Hammond et al., 
2006; Koumenis et al., 2001). 
 
ATF3 mRNA is induced under anoxia independently of HIF-1α 
To determine whether ATF3 mRNA is induced under anoxia we performed a one-step 
RTPCR using MCF-7 cells. Figure 3A shows that the steady-state level of ATF3 mRNA 
increases under anoxia after 2 hours and persists at 20 hours. The increase in ATF3 mRNA 
level (Figure 3A) precedes the increase in ATF3 protein level (Figure 2A) suggesting that 
increased ATF3 protein accumulation in anoxia could be due to a later post transcriptional 
event. We do not rule out other non-HIF-1 pathways of increased protein translation that 
could also contribute to ATF3 accumulation under anoxia (Blais et al., 2004). Figure 3B 
shows that the increase in ATF3 mRNA level under anoxia is independent of HIF-1α.  
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ATF3 mRNA is more stable under anoxia than under normoxia 
 Induction of ATF3 mRNA could be through either increased transcription, decreased 
degradation, or both. ATF3 mRNA has been shown to be stabilized by anisomycin and by 
amino acid limitation (Liang et al., 1996; Pan et al., 2005). We investigated the stability of 
ATF3 mRNA under normoxia and anoxia by blocking new mRNA synthesis with 
actinomycin-D. As indicated in Figure 3C, ATF3 mRNA decays more slowly under anoxia 
than under normoxia. Addition of actinomycin-D to normoxic MCF-7 cells resulted in near 
40% decline in ATF3 mRNA after 1 hour, whereas anoxic ATF3 mRNA barely declined, 
suggesting a role for mRNA stability in response to anoxia. We also do not rule out an 
increased ATF3 promoter activity in induction of ATF3 as well. Our preliminary results have 
shown that a 2kb promoter region of ATF3 can activate reporter gene expression up to 4 fold 
under anoxia (data not shown). 
 
The mitochondrial poison cyanide and the 2-Oxoglutarate (OG) dioxygenase inhibitor 
dimethyloxalylglycine (DMOG) do not induce ATF3 
We examined whether anoxia upregulated ATF3 due to blocked mitochondrial 
function. We used cyanide to mimic the anoxic block to mitochondrial electron transport. As 
demonstrated in Figure 4A the anoxic induction of ATF3 or HIF-1α  protein in MCF7 cells or 
Coga cells could not be mimicked by using cyanide (CN), which suggests that ATF3 
induction under anoxia was not dependent on arrest of the respiratory chain (Figure 4A).  
In contrast, DFO could induce ATF3 (Figure 1B, C and 4A). This raises a paradox in 
which mild hypoxic conditions are unable to induce ATF3, but the hypoxia-mimetic iron 
chelator DFO can. To determine if the effects of DFO were through its ability to inhibit the 
PHDs, we tested another mechanistically distinct PHD inhibitor DMOG for its ability to 
induce ATF3. RKO and HIF-1α silenced RKO cells were treated with DMOG and DFO. 
Figure 4B shows that while DMOG (designated as DG, Figure 4B) and DFO can both induce 
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HIF-1α, only DFO could induce ATF3. These results suggest that DFO’s ability to induce 
ATF3 is not through it inhibition of the PHDs, but through another mechanism. Our results 
are consistent with a recent report that ATF3 is induced by DFO but not by hypoxic 
conditions of 1% O2 (Vengellur et al., 2005). However, as this paper was completed, it was 
reported that ATF3 can be induced by DMOG (Elvidge et al., 2006). This is not consistent 
with our findings, and considering DFO to be a hypoxia mimic via solely inhibition of PHDs 
can be misleading.  
 
Inhibiting JNK or adding of the free radical scavenger N-acetyl-l-cystein (NAC) reduces the 
induction of ATF3 under anoxia 
The JNK pathway and free radicals have been previously suggested to contribute to 
gene regulation in hypoxia (Alfranca et al., 2002; Kaelin, 2005). JNK and free radical 
signalling have also been suggested to be regulators of ATF3 expression (Cai et al., 2000; 
Okamoto et al., 2006). We therefore investigated the effect of JNK inhibition and radical 
scavenging on induction of ATF3 protein under anoxia. Figure 4C shows that treating MCF7 
cells with the antioxidant NAC reduced the induction of ATF3 under anoxia. Similarly, the 
JNK inhibitor SP600125 also reduced the levels of induction of ATF3 under anoxia and by 
DFO (Figure 4D). MKK7 can directly regulate JNK activity (Tournier et al., 1997), and this 
signalling pathway has been previously suggested to be involved in regulating the expression 
of ATF3 (Cai et al., 2000; Hartman et al., 2004; Inoue et al., 2004). We investigated the 
potential role of MKK7 in induction of ATF3 protein under anoxia. The results presented in 
Figure 4E demonstrate that 3T3 immortalized MKK7-/- MEFs had reduced levels of ATF3 
expression under anoxia when compared to wtMEFs. We have also observed that primary 
MEFs lacking MKK7 fail to induce ATF3 under anoxia (data not shown, K. Ameri 
unpublished observations). Thus, our data suggest that MKK7 and its downstream target JNK 
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as well as free radicals are potentially involved in regulating ATF3 protein induction under 
anoxia.  
The function of ATF3 in hypoxic/anoxic tumor sites remains unknown. ATF3 has 
been suggested to be critical in metastasis, and has also been reported to be pro-apoptotic as 
well as anti-apoptotic (Francis et al., 2004; Hai & Hartman, 2001; Hartman et al., 2004; 
Ishiguro & Nagawa, 2000). As this paper was completed, it was reported that ATF3 stabilizes 
p53 upon genotoxic stress (Yan et al., 2005), and also induces tubulogenic differentiation in 
endothelial cells and angiogenesis in diabetic angiopathy (Okamoto et al., 2006). Thus, a 
potential role of ATF3 in modulating p53 and angiogenesis under anoxia should be 
investigated.  
In summary, we demonstrate that the anoxic induction of ATF3 protein is independent 
of HIF-1 and p53, but is reduced by MKK7 deficiency, JNK inhibition, and the antioxidant 
NAC.  
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Figure legends 
Figure 1. Induction of ATF3 under hypoxia, anoxia and by DFO in various cell types. 
The human breast cancer cell line MCF-7, and murine B16-F10 melanoma cells were from 
American type culture collection (ATCC) and maintained as described before (Ameri et al., 
2004).  Low passage Coga 12 colon cancer cells were previously isolated and prepared from 
human tumor samples as described (Vecsey-Semjen et al., 2002). Embryonic murine cortical 
neurons (8-10 day cultures) were prepared and maintained as described, (Culmsee et al., 
2003). Cultures were incubated for 24 hours in either desferrioxamine (200 µM DFO) (Sigma, 
Taufkirchen, Germany) or in a humidified gas-regulated incubator-gloved box (InVivo2 400; 
Ruskin, Leeds, United Kingdom) at the indicated oxygen concentrations. For anoxic 
conditions, cells were placed in a humidified anaerobic work station with 5% H2, 5% CO2, 
and 95% N2 (Sheldon Co., Cornelius, OR) and a palladium catalyst. Extracts were made 
directly in the chamber. Protein extracts were made with urea denaturing buffer added directly 
to the cells as described (Ameri et al., 2004), they were quantitated and subjected to reducing 
SDS polyacrylamide (10-12%) gel electrophoresis and electroblotted to PVDF. The rabbit 
polyclonal antibody to ATF3 (sc-188) was from Santa Cruz Biotechnology Inc. (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), the mouse monoclonal antibody to HIF-1α was from 
BD Transduction laboratories (San Jose, CA, USA). (A) Immunoblot analysis shows that 
ATF3 protein is most robustly upregulated under anoxia compared to hypoxic levels of 5%-
0.5% O2, whereas HIF-1α is stabilized at 5% O2. (B) Both DFO and anoxia upregulate ATF3 
and HIF-1α in MCF-7 cells. (C) Upregulation of ATF3 protein by anoxia and DFO is 
common in the cell lines tested. (D) Cells were incubated at the O2 concentrations shown or in 
the presence of DFO for 16 hours. One hour prior to harvesting 10uM BrdU was added and 
Brdu incorporation and DNA content was examined as described (Hammond et al., 2003). 
Experiments were performed at least 3 times. Immunoblot for β actin served as a control 
 14
(anti-β actin antibody was from Sigma, Taufkirchen, Germany). N=normoxia, A=anoxia, 
D=desferrioxamine (DFO). 
Figure 2. Induction of ATF3 protein is not dependent on HIF-1α, p53, a defect in pVHL 
or constitutive normoxic expression of HIF-2α. (A) ATF3 protein is induced in MCF-7 
cells at 8 hours of anoxic incubation, whereas HIF-1α is induced at 4 hours. Hepa-1 and 
Hepa-1 C4 (HIF-1β deficient) cells and generation of HIF-1α deficient mouse embryonic 
fibroblasts (MEFs) have been described before (Chilov et al., 1999; Ryan et al., 2000). DFO 
and/or anoxia induce ATF3 protein similarly in the genetically matched pairs of cells 
including (B) Hepa-1 cells and Hepa-1 C4, (C) wt and HIF-1α deficient MEFs (HIF-1α-/-), 
(D) RKO (human colon carcinoma cells, American Type Culture Collection, ATCC) and 
HIF-1α silenced RKO cells (described in (Papandreou et al., 2006); designated as shHIF1α in 
Figure 2D), and (E) 786-0, and 786-0+VHL human renal cell carcinoma (Maxwell et al., 
1999). Due to a VHL defect, HIF-2α was induced constitutively in 786-0 cells under 
normoxia, whereas 786-0+VHL cells and MCF7 cells did not express HIF-2α in normoxia, 
but did induce HIF-2α in anoxia. ATF3 was induced in all of the cells only under anoxia. (F) 
ATF3 was induced in both wtp53 and p53 null (p53-/-) HCT116 cells after 8 or 24 hours of 
anoxia. Experiments were performed at least 3 times. N=normoxia, A=anoxia. 
Figure 3. ATF3 mRNA is upregulated under anoxia and is more stable than under 
normoxia. Total RNA was extracted from cells by using the Trizol (Invitrogen, Carlsbad, 
CA, USA) method according to the manufacturer’s protocol. RTPCR was carried out by using 
the superscript III one-step method (Invitrogen, Carlsbad, CA). Primers were as follows:                  
ATF3 forward primer CTGCAGAAAGAGTCGGAG, reverse primer TGAGCCCGGACAAT 
ACAC, β-actin forward primer TCACCGAGGCCCCCCTGAACCCTA, reverse primer 
GGCAGTAATCTCCTTCTGCATCCT, Bnip3L forward ATGAATTCATGTCGTCCCACC 
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TAGTCG, reverse primer ATCTCGAGCTTCAGAAATTCTGCGGAGAAAATACCCCC. 
For message stability cells were incubated in normoxia or anoxia for 20 hours and then 
5ug/ml of actinomycin-D (Sigma-Aldrich, Saint Louis, Missouri, USA) was added directly to 
the cells and incubated for the indicated time points after which RNA was extracted. The 
quantity of mRNA was assessed by measuring the intensity of cDNA band on the gel with the 
Image Quant 5.2 program. (A) ATF3 mRNA was upregulated in MCF7 cells in anoxia. (B) 
ATF3 mRNA was upregulated under anoxia in both RKO and shHIF-1α RKO cells after 20 
hours whereas the HIF-1α target gene Bnip3L was only upregulated in RKO cells. (C) As 
indicated, after addition of actinomycin-D, ATF3 mRNA under normoxia was less stable than 
ATF3 mRNA under anoxia. The graph illustrates the means + S.E. for 3 experiments. Results 
are normalized to the internal control β-actin. RTPCR is a representative experiment. 
N=normoxia, A=anoxia, act.-D=actinomycin-D. 
Figure 4. ATF3 is not induced by cyanide or DMOG, but induction under anoxia is 
reduced by addition of the free radical scavenger NAC and by JNK inhibition. (A) 
Potassium cyanide (5mM, Sigma, Taufkirchen, Germany) and DFO (200µM) were added 
directly to the cells and incubated for 24 hours in a 5% CO2 incubator. Immunoblot analysis 
shows that low passage human Coga 12 and Coga 5 colon cancer cells and MCF-7 breast 
cancer cell line did not induce ATF3 (or HIF-1α) by cyanide but did by DFO. (B) RKO cells 
and shHIF-1α RKO cells were incubated with 200µM DFO or 2mM DMOG for 24 hours. 
ATF3 protein was induced only by DFO and not by DMOG in both RKO and shHIF-1α, 
whereas HIF-1α was induced by both DFO and DMOG. (C) 10mM NAC was added to the 
cells for 1 hour in a 5% CO2 incubator prior to treatment with anoxia for 24 hours. Addition 
of NAC reduced the anoxic induction of ATF3. (D) For each separate experiment a fresh 
batch of the JNK inhibitor SP600125 (Calbiochem Novabiochem, Bad Soden, Germany) was 
used. Fresh SP600125 was dissolved in 100% methanol and added to cells at a final 
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concentration of 50 µM for 1.5 hours prior to treatment with DFO or anoxia for 24 hours. As 
indicated, ATF3 induction by anoxia or DFO was reduced when cells were treated with the 
JNK inhibitor SP600125. (E) 3T3 immortalized MKK7-/-mouse embryonic fibroblasts (MEFs) 
were described previously (Tournier et al., 2001; Ventura et al., 2004). Fibroblasts were 
seeded in 6 cm petridishes, and incubated in a 5% CO2 incubator at 37 oC for 24 hours until 
approximately 80% confluency. Cells were then subjected to anoxia for 20 hours. As 
indicated, ATF3 protein was induced to a greater level in wtMEFs compared to MKK7-/- 
MEFs. Experiments were repeated 3 times. N=normoxia, A=Anoxia, D=desferrioxamine 
(DFO), DG=DMOG, CN=cyanide, Ji=JNK inhibitor, MEF=mouse embryonic fibroblast. 
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